{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:59:05Z","timestamp":1762149545339,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970967"],"award-info":[{"award-number":["31970967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.expneurol.2023.114346","type":"journal-article","created":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T17:09:35Z","timestamp":1675616975000},"page":"114346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation"],"prefix":"10.1016","volume":"362","author":[{"given":"Ying-Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Ting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2023.114346_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114346_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2023.114346_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.25826","article-title":"Brain insulin signaling, Alzheimer disease pathology, and cognitive function","volume":"88","author":"Arvanitakis","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0020","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/acschemneuro.9b00516","article-title":"Catalytic prion-like cross-talk between a key Alzheimer\u2019s disease tau-fragment R3 and the type 2 diabetes peptide IAPP","volume":"10","author":"Arya","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0025","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1523\/JNEUROSCI.2260-13.2014","article-title":"Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression","volume":"34","author":"Baisley","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0030","doi-asserted-by":"crossref","first-page":"14587","DOI":"10.1074\/jbc.M117.774893","article-title":"Key aromatic\/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly","volume":"292","author":"Bakou","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2012.01.006","article-title":"Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders","volume":"134","author":"Balaratnasingam","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2023.114346_bb0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","article-title":"Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein","volume":"165","author":"Bellucci","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0045","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2013.08.029","article-title":"Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer\u2019s disease tauopathies","volume":"35","author":"Belrose","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114346_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-161192","article-title":"The link between type 2 diabetes and neurodegeneration: roles for amyloid-beta, amylin, and tau proteins","volume":"59","author":"Bharadwaj","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114346_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100936","article-title":"Diabetes drugs in the fight against Alzheimer\u2019s disease","volume":"54","author":"Boccardi","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2023.114346_bb0060","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0025-17.2017","article-title":"Role of endoplasmic reticulum stress in learning and memory impairment and Alzheimer\u2019s disease-like neuropathology in the PS19 and APP(Swe) mouse models of Tauopathy and amyloidosis","volume":"4","author":"Briggs","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.expneurol.2023.114346_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein MISFOLDING, amyloid formation, and human disease: a summary of Progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0075","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2023.114346_bb0080","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1096\/fj.11-186650","article-title":"Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice","volume":"25","author":"Dumont","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2023.114346_bb0085","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1093\/hmg\/dds355","article-title":"Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice","volume":"21","author":"Dumont","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2023.114346_bb0090","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid beta (Abeta) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer\u2019s disease Brain - special emphasis on PI3K-Akt pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3233\/JAD-190161","article-title":"Effects of amylin against amyloid-beta-induced Tauopathy and synapse loss in primary neurons","volume":"70","author":"Gan","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114346_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1021\/acschemneuro.7b00396","article-title":"Islet amyloid polypeptide promotes amyloid-Beta aggregation by binding-induced Helix-unfolding of the Amyloidogenic Core","volume":"9","author":"Ge","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000026432","article-title":"Human amylin stimulates inflammatory cytokine secretion from human glioma cells","volume":"7","author":"Gitter","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.expneurol.2023.114346_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JAD-180433","article-title":"Neuroprotective effects of amylin analogues on Alzheimer\u2019s disease pathogenesis and cognition","volume":"66","author":"Grizzanti","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114346_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0125","doi-asserted-by":"crossref","first-page":"29396","DOI":"10.1038\/srep29396","article-title":"Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114346_bb0130","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/npp.2017.8","article-title":"Intranasal lactoferrin enhances alpha-secretase-dependent amyloid precursor protein processing via the ERK1\/2-CREB and HIF-1alpha pathways in an Alzheimer\u2019s disease mouse model","volume":"42","author":"Guo","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2023.114346_bb0135","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1074\/jbc.M117.811315","article-title":"Endoplasmic reticulum stress responses in mouse models of Alzheimer\u2019s disease: overexpression paradigm versus knockin paradigm","volume":"293","author":"Hashimoto","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/VHRM.S1978","article-title":"Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk","volume":"4","author":"Hoogwerf","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.expneurol.2023.114346_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2023.114346_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10495-011-0656-3","article-title":"beta-amyloid protein (Abeta) and human amylin regulation of apoptotic genes occurs through the amylin receptor","volume":"17","author":"Jhamandas","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.expneurol.2023.114346_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","article-title":"Actions of beta-amyloid protein on human neurons are expressed through the amylin receptor","volume":"178","author":"Jhamandas","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41467-021-27702-w","article-title":"Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to tau and ass pathology","volume":"13","author":"Jiwaji","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2023.114346_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.626636","article-title":"A systematic review of glucose transport alterations in Alzheimer\u2019s disease","volume":"15","author":"Kyrtata","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.neuron.2016.09.022","article-title":"Reduction of Nuak1 decreases tau and reverses phenotypes in a tauopathy mouse model","volume":"92","author":"Lasagna-Reeves","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114346_bb0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/mp.2014.81","article-title":"HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer\u2019s disease in a three cohorts study","volume":"20","author":"Leduc","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2023.114346_bb0185","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2023.114346_bb0190","first-page":"8","article-title":"Iron exposure and the cellular mechanisms linked to neuron degeneration in adult mice","author":"Li","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2023.114346_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2023.114346_bb0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.25570","article-title":"Amylin as a potential link between type 2 diabetes and alzheimer disease","volume":"86","author":"Martinez-Valbuena","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0205","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.0774-15.2016","article-title":"Tau-driven neuronal and neurotrophic dysfunction in a mouse model of early Tauopathy","volume":"36","author":"Mazzaro","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113076","article-title":"GluT4: a central player in hippocampal memory and brain insulin resistance","volume":"323","author":"McNay","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2016.02.034","article-title":"Amylin-mediated control of glycemia, energy balance, and cognition","volume":"162","author":"Mietlicki-Baase","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2023.114346_bb0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuropharm.2017.12.016","article-title":"Amylin in Alzheimer\u2019s disease: pathological peptide or potential treatment?","volume":"136","author":"Mietlicki-Baase","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2023.114346_bb0225","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2023.114346_bb0230","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1002\/jcb.28094","article-title":"A shared comparison of diabetes mellitus and neurodegenerative disorders","volume":"120","author":"Morsi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/15333175211012867","article-title":"Oral amylin treatment reduces the pathological Cascade of Alzheimer\u2019s disease in a mouse model","volume":"36","author":"Na","year":"2021","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.expneurol.2023.114346_bb0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/13813455.2018.1534244","article-title":"Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer\u2019s disease","volume":"126","author":"Nassar","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-180421","article-title":"Neuroprotective effects of the amylin analog, Pramlintide, on Alzheimer\u2019s disease are associated with oxidative stress regulation mechanisms","volume":"69","author":"Patrick","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114346_bb0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fendo.2018.00331","article-title":"Modulation of Amyloidogenesis controlled by the C-terminal domain of islet amyloid polypeptide shows new functions on hepatocyte cholesterol metabolism","volume":"9","author":"Pulido-Capiz","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.expneurol.2023.114346_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","article-title":"Islet amyloid polypeptide: a partner in crime with Abeta in the pathology of Alzheimer\u2019s disease","volume":"13","author":"Raimundo","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brainres.2009.05.019","article-title":"Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer\u2019s disease risk","volume":"1280","author":"Rodriguez-Rodriguez","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2023.114346_bb0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","article-title":"Levels of retinal IAPP are altered in Alzheimer\u2019s disease patients and correlate with vascular changes and hippocampal IAPP levels","volume":"69","author":"Schultz","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114346_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4981814","article-title":"Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease","volume":"2020","author":"Sun","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.expneurol.2023.114346_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021050","article-title":"P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating","volume":"6","author":"Takeuchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2023.114346_bb0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tem.2015.11.003","article-title":"Targeting insulin-degrading enzyme to treat type 2 diabetes mellitus","volume":"27","author":"Tang","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2023.114346_bb0290","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1096\/fj.201700431R","article-title":"Amyloid-beta and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2023.114346_bb0295","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/path.5674","article-title":"Combination of human tau and islet amyloid polypeptide exacerbates metabolic dysfunction in transgenic mice","volume":"254","author":"Wijesekara","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0300","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","article-title":"Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer\u2019s disease","volume":"82","author":"Yamamoto","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2023.114346_bb0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2023.114346_bb0310","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pneurobio.2017.03.001","article-title":"Islet amyloid polypeptide: another key molecule in Alzheimer\u2019s pathogenesis?","volume":"153","author":"Zhang","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0315","doi-asserted-by":"crossref","first-page":"43617","DOI":"10.18632\/oncotarget.17116","article-title":"Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP\/PS1 mice","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.expneurol.2023.114346_bb0320","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","article-title":"Alpha-lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S tau transgenic mice","volume":"14","author":"Zhang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2023.114346_bb0325","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnagi.2020.00262","article-title":"Alpha-lipoic acid maintains Brain glucose metabolism via BDNF\/TrkB\/HIF-1alpha signaling pathway in P301S mice","volume":"12","author":"Zhang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2023.114346_bb0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13024-022-00518-y","article-title":"Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2023.114346_bb0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2023.114346_bb0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trci.2016.12.002","article-title":"An amylin analog used as a challenge test for Alzheimer's disease","volume":"3","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement (N. Y.)"},{"key":"10.1016\/j.expneurol.2023.114346_bb0345","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuropharm.2017.03.030","article-title":"Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease","volume":"119","author":"Zhu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2023.114346_bb0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.9826","article-title":"Association of plasma amylin concentration with alzheimer disease and brain structure in older adults","volume":"2","author":"Zhu","year":"2019","journal-title":"JAMA Netw. Open"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:55:31Z","timestamp":1762149331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488623000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":70,"alternative-id":["S0014488623000304"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114346","relation":{},"ISSN":["0014-4886"],"issn-type":[{"type":"print","value":"0014-4886"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114346"}}